Unlock the value in your FFPE samples
25 Oct 2021
FFPE tissue samples with a low abundance of nucleic acid present challenges for cancer genomics as they can produce insufficient DNA or RNA for downstream analyses. In this video, Purigen Biosystems review the data that demonstrates the ability of the Ionic® Purification System to recover sufficient yields of high-quality DNA, RNA, or miRNA from FFPE tissue samples.
About the company
Purigen Biosystems
Purigen Biosystems' transformative Ionic Purification System provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. The Ionic® Purification System is compatible with a range of samples including cells and FFPE. Purigen is proudly affliated with StartX Med, a Stanford-University-affliated nonprofit technology accelerator, and the California Life Sciences Institute’s (CLSI) FAST Advisory Program.
Related products
Request Quote for All Products
Ionic® Purification System
Purigen BiosystemsThe Ionic® Purification System is a benchtop platform that provides automated extraction of DNA and RNA from biological samples. Using cutting-edge technology based on isotachophoresis, the Ionic system separates DNA and RNA freely in solution, without binding to or stripping nucleic acids from physical surfaces. The workflow is simple and efficient, while producing higher yields with higher purity, consistently and reliably.
